Genetic susceptibility to heroin addiction: A candidate gene association study

Genes, Brain and Behavior

Volumn 7, Issue 7, 2008, Pages 720-729

  Levran, O ^a   Londono, D ^a   O'Hara, K ^a   Nielsen, D A ^a   Peles, E ^b   Rotrosen, J ^c   Casadonte, P ^c   Linzy, S ^d   Randesi, M ^a   Ott, J ^a,e   Adelson, M ^a,b,d   Kreek, M J ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Dr Miriam and Sheldon G Adelson Clinic for Drug Abuse Treatment and Research   (United States)

^e Chinese Academy of Sciences and China National Center for Bioinformation   (China)

Author keywords

Association study; Candidate gene; Heroin addiction

Indexed keywords

CASEIN KINASE IEPSILON; DELTA OPIATE RECEPTOR; GALANIN; KAPPA OPIATE RECEPTOR; METHADONE; SEROTONIN RECEPTOR;

ARTICLE; CAUCASIAN; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HEROIN DEPENDENCE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

CASEIN KINASE IEPSILON; DNA; FEMALE; GALANIN; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HEROIN DEPENDENCE; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MULTIGENE FAMILY; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, KAPPA; RECEPTORS, OPIOID, MU; RECEPTORS, SEROTONIN;

EID: 52949148918     PISSN: 16011848     EISSN: 1601183X     Source Type: Journal    
DOI: 10.1111/j.1601-183X.2008.00410.x     Document Type: Article

References (76)

1. Barrett, J.C., Fry, B., Maller, J. Daly, M.J 2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21, 263 265.
2. Bart, G., LaForge, K.S., Borg, L., Lilly, C., Ho, A. Kreek, M.J 2006) Altered levels of basal cortisol in healthy subjects with a 118G allele in exon 1 of the Mu opioid receptor gene. Neuropsychopharmacol 31, 2313 2317.
3. Beaulieu, J.M., Sotnikova, T.D., Yao, W.D., Kockeritz, L., Woodgett, J.R., Gainetdinov, R.R. Caron, M.G 2004) Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade. Proc Natl Acad Sci U S A 101, 5099 5104.
4. Belfer, I., Hipp, H., McKnight, C., Evans, C., Buzas, B., Bollettino, A., Albaugh, B., Virkkunen, M., Yuan, Q., Max, M.B., Goldman, D. Enoch, M.A 2006) Association of galanin haplotypes with alcoholism and anxiety in two ethnically distinct populations. Mol Psychiatry 11, 301 311.
5. Bond, C., LaForge, K.S., Tian, M., Melia, D., Zhang, S., Borg, L., Gong, J., Schluger, J., Strong, J.A., Leal, S.M., Tischfield, J.A., Kreek, M.J. Yu, L 1998) Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction. Proc Natl Acad Sci U S A 95, 9608 9613.
6. Benjamini, Y. Hochberg, Y 1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B 57, 289 300.
7. Carr, L.G., Foroud, T., Stewart, T., Castelluccio, P., Edenberg, H.J. Li, T.K 2002) Influence of ADH1B polymorphism on alcohol use and its subjective effects in a Jewish population. Am J Med Genet 112, 138 143.
8. Cheng, C.Y., Hong, C.J., Yu, Y.W., Chen, T.J., Wu, H.C. Tsai, S.J 2005) Brain-derived neurotrophic factor (Val66Met) genetic polymorphism is associated with substance abuse in males. Brain Res Mol Brain Res. 140, 86 90.
9. Devlin, B., Roeder, K. Wasserman, L 2001) Genomic control, a new approach to genetic-based association studies. Theor Popul Biol 60, 155 166.
10. Drakenberg, K., Nikoshkov, A., Horvath, M.C., Fagergren, P., Gharibyan, A., Saarelainen, K., Rahman, S., Nylander, I., Bakalkin, G., Rajs, J., Keller, E. Hurd, Y.L 2006) Mu opioid receptor A118G polymorphism in association with striatal opioid neuropeptide gene expression in heroin abusers. Proc Natl Acad Sci U S A 103, 7883 7888.
11. Enoch, M.A., Shen, P.H., Xu, K., Hodgkinson, C. Goldman, D 2006) Using ancestry-informative markers to define populations and detect population stratification. J Psychopharmacol 20, 19 26.
12. Filliol, D., Ghozland, S., Chluba, J., Martin, M., Matthes, H.W., Simonin, F., Befort, K., Gaveriaux-Ruff, C., Dierich, A., LeMeur, M., Valverde, O., Maldonado, R. Kieffer, B.L 2000) Mice deficient for delta- and mu-opioid receptors exhibit opposing alterations of emotional responses. Nat Genet 25, 195 200.
13. Franke, P., Nothen, M.M., Wang, T., Neidt, H., Knapp, M., Lichtermann, D., Weiffenbach, O., Mayer, P., Hollt, V., Propping, P. Maier, W 1999) Human delta-opioid receptor gene and susceptibility to heroin and alcohol dependence. Am J Med Genet 88, 462 464.
14. Gabriel, S.B., Schaffner, S.F., Nguyen, H., Moore, J.M., Roy, J., Blumenstiel, B., Higgins, J., DeFelice, M., Lochner, A., Faggart, M., Liu-Cordero, S.N., Rotimi, C., Adeyemo, A., Cooper, R., Ward, R., Lander, E.S., Daly, M.J. Altshuler, D 2002) The structure of haplotype blocks in the human genome. Science 296, 2225 2229.
15. Gerra, G., Leonardi, C., Cortese, E., D'Amore, A., Lucchini, A., Strepparola, G., Serio, G., Farina, G., Magnelli, F., Zaimovic, A., Mancini, A., Turci, M., Manfredini, M. Donnini, C 2007) Human kappa opioid receptor gene (OPRK1) polymorphism is associated with opiate addiction. Am J Med Genet B Neuropsychiatr Genet 144, 771 775.
16. Glatt, S.J., Bousman, C., Wang, R.S., Murthy, K.K., Rana, B.K., Lasky-Su, J.A., Zhu, S.C., Zhang, R., Li, J., Zhang, B., Li, J., Lyons, M.J., Faraone, S.V. Tsuang, M.T 2007) Evaluation of OPRM1 variants in heroin dependence by family-based association testing and meta-analysis. Drug Alcohol Depend 90, 159 165.
17. Gomes, I., Jordan, B.A., Gupta, A., Trapaidze, N., Nagy, V. Devi, L.A 2000) Heterodimerization of mu and delta opioid receptors: a role in opiate synergy. J Neurosci 20, RC110.
18. Hawes, J.J., Brunzell, D.H., Narasimhaiah, R., Langel, U., Wynick, D. Picciotto, M.R 2008) Galanin protects against behavioral and neurochemical correlates of opiate reward. Neuropsychopharmacol 33, 1864 1873.
19. Hoehe, M.R., Kopke, K., Wendel, B., Rohde, K., Flachmeier, C., Kidd, K.K., Berrettini, W.H. Church, G.M 2000) Sequence variability and candidate gene analysis in complex disease: association of mu opioid receptor gene variation with substance dependence. Hum Mol Genet 9, 2895 2908.
20. Holmes, A. Picciotto, M.R 2006) Galanin: a novel therapeutic target for depression, anxiety disorders and drug addiction? CNS Neurol Disord Drug Targets 5, 225 232.
21. Kellogg, S.H., McHugh, P.F., Bell, K., Schluger, J.H., Schluger, R.P., LaForge, K.S., Ho, A. Kreek, M.J 2003) The Kreek-McHugh-Schluger-Kellogg scale: a new, rapid method for quantifying substance abuse and its possible applications. Drug Alcohol Depend 69, 137 150.
22. Kendler, K.S., Jacobson, K.C., Prescott, C.A. Neale, M.C 2003) Specificity of genetic and environmental risk factors for use and abuse/dependence of cannabis, cocaine, hallucinogens, sedatives, stimulants, and opiates in male twins. Am J Psychiatry 160, 687 695.
23. Kloss, B., Price, J.L., Saez, L., Blau, J., Rothenfluh, A., Wesley, C.S. Young, M.W 1998) The Drosophila clock gene double-time encodes a protein closely related to human casein kinase I epsilon. Cell 94, 97 107.
24. Koob, G. Kreek, M.J 2007) Stress, dysregulation of drug reward pathways, and the transition to drug dependence. Am J Psychiatry 164, 1149 1159.
25. Kreek, M.J. LaForge, K.S 2007) Stress responsivity, addiction, and a functional variant of the human mu-opioid receptor gene. Mol Interv 7, 74 78.
26. Kreek, M.J., Bart, G., Lilly, C., LaForge, K.S. Nielsen, D.A 2005a) Pharmacogenetics and human molecular genetics of opiate and cocaine addictions and their treatments. Pharmacol Rev 57, 1 26.
27. Kreek, M.J., Nielsen, D.A., Butelman, E.R. LaForge, K.S 2005b) Genetic influences on impulsivity, risk taking, stress responsivity and vulnerability to drug abuse and addiction. Nat Neurosci 8, 1450 1457.
28. Liu, Y., Wang, Y., Wan, C., Zhou, W., Peng, T., Liu, Y., Wang, Z., Li, G., Cornelisson, G. Halberg, F 2005) The role of mPer1 in morphine dependence in mice. Neuroscience 130, 383 388.
29. Liu, Y., Wang, Y., Jiang, Z., Wan, C., Zhou, W. Wang, Z 2007) The extracellular signal-regulated kinase signaling pathway is involved in the modulation of morphine-induced reward by mPer1. Neuroscience 146, 265 271.
30. Loh, E.W., Tang, N.L., Lee, D.T., Liu, S.I. Stadlin, A 2007) Association analysis of GABA receptor subunit genes on 5q33 with heroin dependence in a Chinese male population. Am J Med Genet B Neuropsychiatr Genet 144, 439 443.
31. Loh el, W., Fann, C.S., Chang, Y.T., Chang, C.J. Cheng, A.T 2004) Endogenous opioid receptor genes and alcohol dependence among Taiwanese Han. Alcohol Clin Exp Res 28, 15 19.
32. Lucki, I 1998) The spectrum of behaviors influenced by serotonin. Biol Psychiatry 44, 151 162.
33. Mayer, P., Rochlitz, H., Rauch, E., Rommelspacher, H., Hasse, H.E., Schmidt, S. Hollt, V 1997) Association between a delta opioid receptor gene polymorphism and heroin dependence in man. Neuroreport 8, 2547 2550.
34. McClung, C.A., Sidiropoulou, K., Vitaterna, M., Takahashi, J.S., White, F.J., Cooper, D.C. Nestler, E.J 2005) Regulation of dopaminergic transmission and cocaine reward by the Clock gene. Proc Natl Acad Sci U S A 102, 9377 9381.
35. McLaughlin, J.P., Marton-Popovici, M. Chavkin, C 2003) κ opioid receptor antagonism and prodynorphin gene disruption block stress-induced behavioral responses. J Neurosci 23, 5674 5683.
36. McLellan, A.T., Kushner, H., Metzger, D., Peters, R., Smith, I., Grissom, G., Pettinati, H. Argeriou, M 1992) The fifth edition of the Addiction Severity Index. J Subst Abuse Treat 9, 199 213.
37. Miller, S.A., Dykes, D.D. Polesky, H.F 1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16, 1215.
38. Neumark, Y.D., Friedlander, Y., Thomasson, H.R. Li, T.K 1998) Association of the ADH2*2 allele with reduced ethanol consumption in Jewish men in Israel: a pilot study. J Stud Alcohol 59, 133 139.
39. Nielsen, D.A., Barral, S., Proudnikov, D., Kellogg, S., Ho, A., Ott, J. Kreek, M.J 2008) TPH2 and TPH1: association of variants and interactions with heroin addiction. Behav Genet 38, 133 150.
40. Nieto, M.M., Guen, S.L., Kieffer, B.L., Roques, B.P. Noble, F 2005) Physiological control of emotion-related behaviors by endogenous enkephalins involves essentially the delta opioid receptors. Neuroscience 135, 305 313.
41. Palmer, A.A., Verbitsky, M., Suresh, R., Kamens, H.M., Reed, C.L., Li, N., Burkhart-Kasch, S., McKinnon, C.S., Belknap, J.K., Gilliam, T.C Phillips, T.J 2005) Gene expression differences in mice divergently selected for methamphetamine sensitivity. Mamm Genome 16, 291 305.
42. Picciotto, M.R., Hawes, J.J., Brunzell, D.H. Zachariou, V 2005) Galanin can attenuate opiate reinforcement and withdrawal. Neuropeptides 39, 313 315.
43. Pritchard, J.K., Stephens, M. Donnelly, P 2000) Inference of population structure using multilocus genotype data. Genetics 155, 945 959.
44. Proudnikov, D., LaForge, K.S., Hofflich, H., Levenstien, M., Gordon, D., Barral, S., Ott, J. Kreek, M.J 2006) Association analysis of polymorphisms in serotonin 1B receptor (HTR1B) gene with heroin addiction: a comparison of molecular and statistically estimated haplotypes. Pharmacogenet Genomics. 16, 25 36.
45. Quock, R.M., Burkey, T.H., Varga, E., Hosohata, Y., Hosohata, K., Cowell, S.M., Slate, C.A., Ehlert, F.J., Roeske, W.R. Yamamura, H.I 1999) The delta-opioid receptor: molecular pharmacology, signal transduction, and the determination of drug efficacy. Pharmacol Rev 51, 503 532.
46. R Development Core Team (2007) R: A Language and Environment for Statistical Computing. R Development Core Team, Vienna, Austria (ISBN 3-900051-07-0).
47. Roberts, A.J., Gold, L.H., Polis, I., McDonald, J.S., Filliol, D., Kieffer, B.L. Koob, G.F 2001) Increased ethanol self-administration in delta-opioid receptor knockout mice. Alcohol Clin Exp Res 25, 1249 1256.
48. Rozenfeld, R. Devi, L.A 2007) Receptor heterodimerization leads to a switch in signaling: beta-arrestin2-mediated ERK activation by mu-delta opioid receptor heterodimers. FASEB J 21, 2455 2465.
49. Ruano, G., Windemuth, A., Kocherla, M., Holford, T., Fernandez, M.L., Forsythe, C.E., Wood, R.J., Kraemer, W.J. Volek, J.S 2006) Physiogenomic analysis of weight loss induced by dietary carbohydrate restriction. Nutr Metab (Lond) 3, 20.
50. Schaid, D.J., Rowland, C.M., Tines, D.E., Jacobson, R.M. Poland, G.A 2002) Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 70, 425 434.
51. Shibuya, A. Yoshida, A 1988) Genotypes of alcohol-metabolizing enzymes in Japanese with alcohol liver diseases: a strong association of the usual Caucasian-type aldehyde dehydrogenase gene (ALDH1(2)) with the disease. Am J Hum Genet 43, 744 748.
52. Simonin, F., Valverde, O., Smadja, C., Slowe, S., Kitchen, I., Dierich, A., Le Meur, M., Roques, B.P., Maldonado, R. Kieffer, B.L 1998) Disruption of the kappa-opioid receptor gene in mice enhances sensitivity to chemical visceral pain, impairs pharmacological actions of the selective kappa-agonist U-50,488H and attenuates morphine withdrawal. EMBO J 17, 886 897.
53. Soubrie, P 1986) Reconciling the role of central serotonin neurons in human and animal behavior. Behav Brain Sci 9, 319 364.
54. Storey, J.D 2003) The positive false discovery rate: a Bayesian interpretation and the q-value. Ann Stat 31, 2013 2035.
55. Storey, J.D. Tibshirani, R 2003) Statistical significance for genomewide studies. Proc Natl Acad Sci USA 100, 9440 9445.
56. Storey, J.D., Taylor, J.E. Siegmund, D 2004) Strong control, conservative point estimation and simultaneous conservative consistency of false discovery rates: a unified approach. J R Stat Soc: B (Stat Method) 66, 187 205.
57. Svenningsson, P., Tzavara, E.T., Liu, F., Fienberg, A.A., Nomikos, G.G. Greengard, P 2002) DARPP-32 mediates serotonergic neurotransmission in the forebrain. Proc Natl Acad Sci USA 99, 3188 3193.
58. Szilagyi, A., Boor, K., Szekely, A., Gaszner, P., Kalasz, H., Sasvari-Szekely, M. Barta, C 2005) Combined effect of promoter polymorphisms in the dopamine D4 receptor and the serotonin transporter genes in heroin dependence. Neuropsychopharmacol Hung. 7, 28 33.
59. Thomasson, H.R., Edenberg, H.J., Crabb, D.W., Mai, X.L., Jerome, R.E., Li, T.K., Wang, S.P., Lin, Y.T., Lu, R.B. Yin, S.J 1991) Alcohol and aldehyde dehydrogenase genotypes and alcoholism in Chinese men. Am J Hum Genet 48, 677 681.
60. Tsuang, M.T., Lyons, M.J., Eisen, S.A., Goldberg, J., True, W., Lin, N., Meyer, J.M., Toomey, R., Faraone, S.V. Eaves, L 1996) Genetic influences on DSM-III-R drug abuse and dependence: a study of 3,372 twin pairs. Am J Med Genet 67, 473 477.
61. Tsuang, M.T., Lyons, M.J., Meyer, J.M., Doyle, T., Eisen, S.A., Goldberg, J., True, W., Lin, N., Toomey, R. Eaves, L 1998) Co-occurrence of abuse of different drugs in men: the role of drug-specific and shared vulnerabilities. Arch Gen Psychiatry 55, 967 972.
62. Unschuld, P.G., Ising, M., Erhardt, A., Lucae, S., Kohli, M., Kloiber, S., Salyakina, D., Thoeringer, C.K., Kern, N., Lieb, R., Uhr, M., Binder, E.B., Muller-Myhsok, B., Holsboer, F. Keck, M.E 2007) Polymorphisms in the galanin gene are associated with symptom-severity in female patients suffering from panic disorder. J Affect Disord 105, 177 184.
63. Veenstra-VanderWeele, J., Qaadir, A., Palmer, A.A., Cook, E.H. Jr. de Wit, H 2006) Association between the casein kinase 1 epsilon gene region and subjective response to D-amphetamine. Neuropsychopharmacol 31, 1056 1063.
64. Wand, G.S., McCaul, M., Yang, X., Reynolds, J., Gotjen, D., Lee, S. Ali, A 2002) The mu-opioid receptor gene polymorphism (A118G) alters HPA axis activation induced by opioid receptor blockade. Neuropsychopharmacol 26, 106 114.
65. Xu, K., Liu, X.H., Nagarajan, S., Gu, X.Y. Goldman, D 2002) Relationship of the delta-opioid receptor gene to heroin abuse in a large Chinese case/control sample. Am J Med Genet 110, 45 50.
66. Xu, K., Lichtermann, D., Lipsky, R.H., Franke, P., Liu, X., Hu, Y., Cao, L., Schwab, S.G., Wildenauer, D.B., Bau, C.H., Ferro, E., Astor, W., Finch, T., Terry, J., Taubman, J., Maier, W. Goldman, D. (2004) Association of specific haplotypes of D2 dopamine receptor gene with vulnerability to heroin dependence in 2 distinct populations. Arch Gen Psychiatry 61, 597 606.
67. Xuei, X., Dick, D., Flury-Wetherill, L., Tian, H.J., Agrawal, A., Bierut, L., Goate, A., Bucholz, K., Schuckit, M., Nurnberger, J. Jr., Tischfield, J., Kuperman, S., Porjesz, B., Begleiter, H., Foroud, T. Edenberg, H.J 2006) Association of the kappa-opioid system with alcohol dependence. Mol Psychiatry 11, 1016 1024.
68. Yamada, K., Hattori, E., Iwayama, Y., Ohnishi, T., Ohba, H., Toyota, T., Takao, H., Minabe, Y., Nakatani, N., Higuchi, T., Detera-Wadleigh, S.D. Yoshikawa, T 2006) Distinguishable haplotype blocks in the HTR3A and HTR3B region in the Japanese reveal evidence of association of HTR3B with female major depression. Biol Psychiatry 60, 192 201.
69. Yuferov, V., Kroslak, T., LaForge, K.S., Zhou, Y., Ho, A. Kreek, M.J 2003) Differential gene expression in the rat caudate putamen after "binge" cocaine administration: advantage of triplicate micro array analysis. Synapse 48, 157 169.
70. Yuferov, V., Fussell, D., LaForge, K.S., Nielsen, D.A., Gordon, D., Ho, A., Leal, S.M., Ott, J. Kreek, M.J 2004) Redefinition of the human kappa opioid receptor gene (OPRK1) structure and association of haplotypes with opiate addiction. Pharmacogenetics 14, 793 804.
71. Yuferov, V., Butelman, E.R. Kreek, M.J 2005) Biological clock: biological clocks may modulate drug addiction. Eur J Hum Genet 13, 1101 1103.
72. Zachariou, V., Brunzell, D.H., Hawes, J., Stedman, D.R., Bartfai, T., Steiner, R.A., Wynick, D., Langel, U. Picciotto, M.R 2003) The neuropeptide galanin modulates behavioral and neurochemical signs of opiate withdrawal. Proc Natl Acad Sci USA 100, 9028 9033.
73. Zhang, H., Luo, X., Kranzler, H.R., Lappalainen, J., Yang, B.Z., Krupitsky, E., Zvartau, E. Gelernter, J 2006) Association between two mu-opioid receptor gene (OPRM1) haplotype blocks and drug or alcohol dependence. Hum Mol Genet 15, 807 819.
74. Zhang, D., Shao, C., Shao, M., Yan, P., Wang, Y., Liu, Y., Liu, W., Lin, T., Xie, Y., Zhao, Y., Lu, D., Li, Y. Jin, L 2007) Effect of mu-opioid receptor gene polymorphisms on heroin-induced subjective responses in a Chinese population. Biol Psychiatry 61, 1244 1251.
75. Zhang, H., Kranzler, H.R., Yang, B.Z., Luo, X. Gelernter, J 2008) The OPRD1 and OPRK1 loci in alcohol or drug dependence: OPRD1 variation modulates substance dependence risk. Mol Psychiatry 13, 531 543.
76. Zou, Y., Liao, G., Liu, Y., Wang, Y., Yang, Z., Lin, Y., Shen, Y., Li, S., Xiao, J., Guo, H., Wan, C. Wang, Z 2007) Association of the 54-nucleotide repeat polymorphism of hPer3 with heroin dependence in Han Chinese population. Genes Brain Behav 7, 26 30.